Eiropas Savienība -
slovēņu -
EMA (European Medicines Agency)
lucentis
novartis europharm limited - ranibizumab - wet macular degeneration; macular edema; diabetes complications; myopia, degenerative; choroidal neovascularization - oftalmologi - zdravilo lucentis je navedeno v odraslih za:zdravljenje neovascular (mokro) starostna degeneracija rumene pege (amd)zdravljenje vida zaradi choroidal neovascularisation (cnv)zdravljenje vida zaradi diabetično degeneracija edem (dme)zdravljenje vida zaradi degeneracija edem sekundarnega do mrežnice vene (veja rvo ali centralne rvo).
Eiropas Savienība -
slovēņu -
EMA (European Medicines Agency)
macugen
pharmaswiss ceska republika s.r.o - pegaptanib - mokra makularna degeneracija - oftalmologi - macugen je indicirano za zdravljenje neovaskularne (mokro) starost degeneracije makule (amd).
Eiropas Savienība -
slovēņu -
EMA (European Medicines Agency)
byooviz
samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - oftalmologi - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
Eiropas Savienība -
slovēņu -
EMA (European Medicines Agency)
ximluci
stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologi - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
Eiropas Savienība -
slovēņu -
EMA (European Medicines Agency)
vabysmo
roche registration gmbh - faricimab - wet macular degeneration; macular edema; diabetes complications - oftalmologi - vabysmo is indicated for the treatment of adult patients with:neovascular (wet) age-related macular degeneration (namd),visual impairment due to diabetic macular oedema (dme).
Slovēnija -
slovēņu -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
advantan 1 mg/g dermalna emulzija
bayer d.o.o. - metilprednizolonaceponat - dermalna emulzija - metilprednizolonaceponat 1 mg / 1 g - metilprednizolonaceponat
Slovēnija -
slovēņu -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
ansyn 1 mg filmsko obložene tablete
actavis group ptc ehf. - anastrozol - filmsko obložena tableta - anastrozol 1 mg / 1 tableta - anastrozol
Slovēnija -
slovēņu -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
arimidex 1 mg filmsko obložene tablete
astrazeneca ab - anastrozol - filmsko obložena tableta - anastrozol 1 mg / 1 tableta - anastrozol
Slovēnija -
slovēņu -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
asolfena 10 mg filmsko obložene tablete
krka, d.d., novo mesto - solifenacin - filmsko obložena tableta - solifenacin 7,5 mg / 1 tableta - solifenacin
Slovēnija -
slovēņu -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
asolfena 5 mg filmsko obložene tablete
krka, d.d., novo mesto - solifenacin - filmsko obložena tableta - solifenacin 3,8 mg / 1 tableta - solifenacin